Cargando…
Patients' Attitudes to Unproven Therapies in Treating COVID-19 Merit Evaluation
Since the outbreak of COVID-19, many randomized controlled trials have been launched to test the efficacy of promising treatments. These trials will offer great promise for future treatment. However, a public health emergency calls for a balance between gathering sound evidence and granting therapeu...
Autores principales: | Li, Hong-tian, Cheng, Zhi-hao, Huang, Yong-ying, Lv, Xi-lin, Zhou, Yu-bo, Dong, Erdan, Liu, Jian-meng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836536/ https://www.ncbi.nlm.nih.gov/pubmed/33521761 http://dx.doi.org/10.1016/j.xinn.2020.100028 |
Ejemplares similares
-
Patients' Attitudes to Unproven Therapies in Treating COVID-19 Merit Evaluation
por: Li, Hong-tian, et al.
Publicado: (2020) -
From hydroxychloroquine to ivermectin: how unproven “cures” can go viral
por: Taccone, Fabio Silvio, et al.
Publicado: (2022) -
Unproven Therapies for Diabetes and Their Implications
por: Kesavadev, Jothydev, et al.
Publicado: (2016) -
Unproven stem cell therapy for macular degeneration
por: Ansari, Zubair A., et al.
Publicado: (2017) -
Phosphoethanolamine and the danger of unproven drugs
por: Pondé, Noam, et al.
Publicado: (2016)